Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating.

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

US President Donald Trump signs an executive order to create a sovereign wealth fund with Scott Bessent, US Treasury ...

Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for KLA in a note issued to investors on Friday, January 31st. Cantor Fitzgerald analyst C. Muse ...

TMC the metals company Inc (TMC) stock saw a modest uptick, ending the day at $1.78 which represents a slight increase of $0.15 or 9.20% from the prior close of $1.63. The stock opened at $1.58 and ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

U.S. President Donald Trump signed an executive order Monday afternoon charging the Treasury and Commerce Departments with ...

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...

The company reported a Q4 adjusted diluted EPS of $0.80 and full-year 2024 adjusted diluted EPS of $7.17, exceeding prior guidance. Revenue guidance for 2025 was raised by $4B to a range of $158B to ...